Related Articles
00 / 00
Request an Appointment
Chief, Nuclear Medicine and PET
Professor, Department of Diagnostic Imaging
Head & Neck Cancer, Neuroendocrine Tumors, Thyroid Cancer, Myeloma, Prostate Cancer, Liver, Gall Bladder & Bile Duct Cancer, Pancreatic Cancer
My main work is in diagnostic imaging using radiotracers for staging, follow-up, and monitoring of various tumors. I also treat patients with unsealed source radiotracer for thyroid cancer, NHL, pancreatic cancer, and bone pain palliation. I’m authorized user for SIR-sphere and Therasphere as well.
Patient first.
Divgi C, Uzzo R, Gatsonis C, Bartz R, Treutner S, Yu JQ, Chen D, Carrasquillo J, Larson S, Bevan P, Russo P: PET/CT Identification of Clear Cell Renal Cell Carcinoma: Results of the REDECT Trial. Journal of Clinical Oncology, January 10, 2013: vol. 31, no. 2, 187-194. [Epub Dec. 3, 2012], PMID: 23213092 PubMed
Lango M, Flieder D, Arrangoiz R, Veloski C, Yu JQ, Li T, Burtness B, Mehra R, Galloway T, Ridge J: Extranodal extension of Metastatic Papillary Thyroid Carcinoma: Correlation with biochemical endpoints, nodal persistence and systemic disease progression. Thyroid, 23(9), 1099-1105 [Epub Feb. 19, 2013], PMID: 23421588 PubMed
Savir-Baruch B, Banks KP, McConathy JE, Molchanova-Cook OP, Parent EE, Takalkar A, Tulchinsky M, Yu JQ, Subramaniam RM, Schuster DM: ACR- ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine- PET/CT for Recurrent Prostate Cancer. Clin Nucl Med. 01 Dec 2018, 43 (12): 909-917, PMID: 30325827
GL Andriole, L Kostakoglu, A Chau, F Duan, U Mahmood, DA Mankoff, DM Schuster, BA Siegel, LOCATE Study Group: The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Management of Patients with Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial. J Urol. 2019 Feb;201(2):322-331, PMID: 30179618
VJ Lowe, F Duan, RM Subramaniam, JD Sicks, J Romanoff, T Bartel, JQM Yu, B Nussenbaum, J Richmon, CD Arnold, D Cognetti, BC Stack Jr: A Multicenter Trial of FDG-PET/CT Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results from ACRIN 6685. Journal of Clinical Oncology Jul 10;37 (20):1704-1712. PMID: 30768363; PMCID: PMC6638599
E Sorenson, F Lambreton, JQ Yu, T Li, CS Denlinger, JE Meyer, ER Sigurdson, JM Farma: Impact of PET/CT for Restaging Patients with Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation, Journal of Surgical Research 243, 242-248, PMID: 31229791
M von Mehren, S George, M Heinrich, S Schuetze, J Yap, JQ Yu, A Abbott, S Litwin, J Crowley, M Belinsky, K Janeway, J Hornick, D Flieder, R Chugh, L Rink, and A Van den Abbeele: Linsitinib (OSI-906) for the treatment of Adult and Pediatric Wild Type Gastrointestinal Stromal Tumors, a SARC Phase II study. Clinical Cancer Research, 2020;26:1837–45. PMID: 31792037
AA Solanki, B Savir-Baruch, SL Liauw, J Michalski, JD Tward, N Vapiwala, EJ Teoh on behalf of the LOCATE study group: LP Adler, GL Andriole, LH Belkoff, D Burzon, A Chau, P Dato, F Duan, M Farwell, S Fogelson, P Gardiner, L Hanna, JM Hoffman, C Intenzo, D Josephson, J Kaminetsky, M Kipper, L Kostakoglu, B Krynyckyi, KE Linder, U Mahmood, H Marques, D Mankoff, J McConathy, J Melnick, MP Miller, W Oh, S Philips, J Rose, B Savir-Baruch, DM Schuster, BA Siegel, DJ Stevens, A Tewari, P Twardowski, P Ward, M Wasserman, S Weick, JQ.(Michael) Yu: 18F-Fluciclovine positron emission tomography in men with biochemical recurrence of prostate cancer after radical prostatectomy and planning to undergo salvage radiotherapy: Results from LOCATE, Practical Radiation Oncology, Vol 10, Issue 5, September–October 2020, Pages 354-362 Collapse